U.S. FDA Issues Emergency Authorization for Second COVID-19 Vaccine

In COVID-19, Latest News by Precision Vaccinations

The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the Moderna COVID-19 Vaccine for distribution in the USA for use in individuals 18 years of age and older.
The Moderna COVID-19 Vaccine (mRNA-1273) contains messenger RNA (mRNA), which is genetic material. 
Announced on December 18, 2020, this is the second FDA authorization of an experimental vaccine to prevent COVID-19.

Read More